Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/25/24 → 05/28/26 |
Funding
- Parexel International LLC: $40,736.70
UCB Biopharma: A Dose-Blinded Extension Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of UCB0599 in Study Participants with Parkinson's Disease
- Maurer, Carine (PI)
- Schwartz, Guy (CoPI)
Project: Research